- Multiple banks are rejecting Anthropic IPO buy orders from mainland China and Hong Kong, Bloomberg reported, citing US export-control rules known as ITAR.
- Goldman Sachs and Morgan Stanley are leading Anthropic’s offering, with 20 other banks involved; shares are set to price on November 18.
- Anthropic’s stock is expected to trade on Nasdaq under the ticker ANT, with the restriction echoing similar limits applied during SpaceX’s IPO.
- Anthropic has blocked Chinese-controlled firms from its AI services and says it has exposed large-scale distillation attacks from DeepSeek, Moonshot, and MiniMax.
What Happened
Investors from mainland China and Hong Kong are being shut out of Anthropic’s IPO, The Decoder reported on November 13, 2026, citing Bloomberg. Multiple banks have rejected buy orders from those regions or consider allocations unlikely, citing ITAR, the US export-control rules governing defense-related goods.
Why It Matters
The restriction follows Anthropic’s IPO drawing orders for multiple times the available shares and mirrors limits applied during SpaceX’s IPO. Anthropic’s products are not officially available in China or Hong Kong, and the company’s relationship with the country has been defined largely by confrontation.
Technical Details
Goldman Sachs and Morgan Stanley are leading the offering, with 20 other banks involved; the stock is expected to price on November 18 and trade on Nasdaq under the ticker ANT. Anthropic has blocked firms under Chinese control from its AI services and says it has exposed large-scale distillation attacks involving roughly 16 million queries from DeepSeek, Moonshot, and MiniMax.
Who’s Affected
Institutional and individual investors in mainland China and Hong Kong are excluded from direct participation in one of the year’s largest AI IPOs, while Goldman Sachs, Morgan Stanley, and the other underwriting banks absorb the compliance risk of screening orders.
What’s Next
Anthropic declined to comment on the restrictions, and the IPO remains on track to price November 18, with investors watching whether broader export-control scrutiny affects demand from other regions.